THE EFFECT OF CO-PROCESSED EXCIPIENTS DURING FORMULATION AND EVALUATION OF PEDIARIC LEVETIRACETAM ORODISPERSIBLE TABLETS IN RATS

Authors

  • MAHMOUD H. TEAIMA Department of Pharmaceutics and industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt https://orcid.org/0000-0002-7565-301X
  • HUSSIEN MOHAMED AHMED EL MESSIRY Pharmaceutics Department, Egyptian Drug Authority, Cairo, Egypt https://orcid.org/0000-0002-3517-2027
  • TASNEEM DAHI OSMAN Pharmaceutics Department, Egyptian Drug Authority, Cairo, Egypt
  • MOHAMED A. EL-NABARAWI Department of Pharmaceutics and industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt https://orcid.org/0000-0003-0070-1969
  • DOAA A. HELAL Department of Pharmaceutics, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt https://orcid.org/0000-0002-1222-8112

DOI:

https://doi.org/10.22159/ijap.2023v15i1.45298

Keywords:

Epilepsy, Levetiracetam (LVT), ODT, Pharmaburst® 500, Direct compression

Abstract

Objective: The main aim of this research was to make cost-effective taste-masking oral pediatric orodispersible tablets (ODTs) of Levetiracetam as an antiepileptic drug (AED) using various co-processed excipients by direct compression method.

Methods: Eight kinds of ready-made co-processed excipients in addition to sucralose and menthol as a sweetener were utilized. The weight variation, drug content, friability, in-vitro disintegration, dissolution time, hardness, thickness, and pharmacokinetics of the produced ODTs were determined.

Results: The optimized formula (F5) containing Pharmaburst® 500 showed the shortest disintegration time (11.66 sec) and more than 98% of Levetiracetam within 10 min(Q10). The Pharmacokinetic study of this optimum formula (F5) in rats using HPLC-UV detector showed 26.904 ± 2.027ng/ml as the Cmax and 101.935 ± 0.894 hr.ng/mL as AUC compared to commercial Tiratam® solution 10.421 ± 0.295ng/ml and 23.135 ± 0.43 hr.ng/mL respectively.

Conclusion: Levetiracetam orally orodispersible tablets were successfully prepared with acceptable hardness, satisfactory taste, and rapid disintegration in the oral cavity avoiding first-pass metabolism to yield the desired rapid effect in facing epilepsy for patients who experience dysphagia like pediatric and geriatric. In addition to the unconsciousness of the epileptic patient followed the seizure attack.

Downloads

Download data is not yet available.

References

Pack AM. Epilepsy overview and revised classification of seizures and epilepsies. CONTINUUM: Lifelong Learning in Neurology. 2019;25(2):306-21.

Stein MA, Kanner AM. Management of newly diagnosed epilepsy. Drugs. 2009;69(2):199-222.

Sankaraneni R, Lachhwani D. Antiepileptic drugs—a review. Pediatric annals. 2015;44(2): e36-e42.

Jain KK. An assessment of levetiracetam as an anti-epileptic drug. Expert opinion on investigational drugs. 2000;9(7):1611-24.

Laffleur F, Keckeis V. Advances in drug delivery systems: Work in progress still needed? International journal of pharmaceutics. 2020; 590:119912.

Ansari KK, Sharma N. Formulation and evaluation of orodispersible tablets of lornoxicam. Journal of Drug Delivery and Therapeutics. 2018;8(6):225-8.

Dey P, Maiti S. Orodispersible tablets: A new trend in drug delivery. J Nat Sci Biol Med. 2010;1(1):2-5.

Conceição J, Adeoye O, Cabral-Marques H, Concheiro A, Alvarez-Lorenzo C, Sousa Lobo JM. Orodispersible carbamazepine/hydroxypropyl-β-cyclodextrin tablets obtained by direct compression with five-in-one co-processed excipients. AAPS PharmSciTech. 2020;21(2):1-10.

Moutasim MY, ElMeshad AN, El-Nabarawi MA. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation. Drug delivery and translational research. 2017;7(3):450-9.

Moqbel HA, ElMeshad AN, El-Nabarawi MA. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets. Drug Development and Industrial Pharmacy. 2017;43(5):742-50.

El-Nabarawi MA, Teaima MH, Hamid MMA, Shoman NA, Mohamed AI, El-Sahar A. Formulation, evaluation and antioxidant activity of caffeine fast melt tablets. Research Journal of Pharmacy and Technology. 2018;11(7):3131-8.

Donauer N, Löbenberg R. A mini review of scientific and pharmacopeial requirements for the disintegration test. International journal of pharmaceutics. 2007;345(1-2):2-8.

Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)–a novel solid oral dosage form for paediatric use. European journal of pharmaceutics and biopharmaceutics. 2011;78(3):462-9.

Fouad SA, Malaak FA, El-Nabarawi MA, Abu Zeid K. Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: in-vitro optimization/in-vivo evaluation. PLoS One. 2020;15(12): e0244646.

Engelbrecht L, Grobler C, Rheeders M. A simple and cost‐effective HPLC‐UV method for the detection of levetiracetam in plasma/serum of patients with epilepsy. Biomedical Chromatography. 2017;31(10): e3969.

Chaowalit M, Worawan S, Jirapornchai S, Apirak S, Krisana K. Preformulation and physical properties study of fast disintegrating tablets from thai traditional formula. International Journal of Pharmacy and Pharmaceutical Sciences.2014;6(4): 0975-1491.

Widodo RT, Hassan A. Compression and mechanical properties of directly compressible pregelatinized sago starches. Powder Technology. 2015; 269:15-21.

Validation of methodology for assay, pharmaceutical equivalence, and comparative dissolution profile for tablets containing amlodipine besylate. Journal of Applied Pharmaceutical Science. 2019;9(11):93-100.

Pabari R, Ramtoola Z. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. Journal of young pharmacists. 2012;4(3):157-63.

Brniak W, Jachowicz R, Krupa A, Skorka T, Niwinski K. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Pharmaceutical development and technology. 2013;18(2):464-74.

Abdelmonem R, El tahan M, EL-Nabarawi M. Development and evaluation of taste masked oro-disintegrating tablets of itopride hcl using different co-processed excipients: pharmacokinetics study on rabbits. International Journal of Pharmacy and Pharmaceutical Sciences.2022;14(3): 0975-7058

Chaerunisaa A Y, Sriwidodo S and Abdassah M. Microcrystalline Cellulose as Pharmaceutical Excipient. Pharmaceutical Formulation Design Recent Practices.2019: ch.1, p.p.1-21.

Published

21-10-2022

How to Cite

TEAIMA, M. H., EL MESSIRY, H. M. A., DAHI OSMAN, T., A. EL-NABARAWI, M., & A. HELAL, D. (2022). THE EFFECT OF CO-PROCESSED EXCIPIENTS DURING FORMULATION AND EVALUATION OF PEDIARIC LEVETIRACETAM ORODISPERSIBLE TABLETS IN RATS. International Journal of Applied Pharmaceutics, 15(1). https://doi.org/10.22159/ijap.2023v15i1.45298

Issue

Section

Original Article(s)